Adjunctive nutritional interventions in schizophrenia: A systematic review of randomised clinical trials
Abstract
Background & aims: Schizophrenia is a serious mental disorder involving cognitive, metabolic and functional impairments, often exacerbated by the side effects of pharmacological treatment. In this context, nutritional interventions have been investigated as adjunctive strategies aimed at improving clinical and metabolic outcomes. This study aimed to evaluate the effectiveness of nutritional interventions in schizophrenia, considering different dietary approaches and nutritional supplements.
Methods: A systematic review was conducted according to Cochrane recommendations, including randomised clinical trials investigating nutritional supplementation or dietary interventions in patients with schizophrenia and evaluating clinical, metabolic and cognitive outcomes. Data selection and extraction were performed independently by two reviewers, and methodological quality was assessed using validated instruments.
Results: Nine randomised clinical trials were included. Probiotic-based interventions, particularly when combined with vitamin D or selenium, were associated with improvements in metabolic parameters and selected inflammatory markers. n-3 fatty acid supplementation demonstrated effects on triglyceride concentrations and neurotrophic markers. Plant-derived bioactive compounds were associated with improvements in negative symptoms and stress-related measures. However, findings varied across studies, reflecting heterogeneity in intervention protocols, dosage regimens and…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.